APA (7th ed.) Citation

Hiroshi Nomoto, Kenichi Kito, Hiroshi Iesaka, Yuki Oe, Shinichiro Kawata, Kazuhisa Tsuchida, . . . Tatsuya Atsumi. (2023). Favorable Effect of Pemafibrate on Insulin Resistance and β-Cell Function in Subjects with Type 2 Diabetes and Hypertriglyceridemia: A Subanalysis of the PARM-T2D Study. MDPI AG.

Chicago Style (17th ed.) Citation

Hiroshi Nomoto, et al. Favorable Effect of Pemafibrate on Insulin Resistance and β-Cell Function in Subjects with Type 2 Diabetes and Hypertriglyceridemia: A Subanalysis of the PARM-T2D Study. MDPI AG, 2023.

MLA (9th ed.) Citation

Hiroshi Nomoto, et al. Favorable Effect of Pemafibrate on Insulin Resistance and β-Cell Function in Subjects with Type 2 Diabetes and Hypertriglyceridemia: A Subanalysis of the PARM-T2D Study. MDPI AG, 2023.

Warning: These citations may not always be 100% accurate.